Clinical Trial Update: Evaluation of AMG 714 for Vitiligo [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating AMG 714 for vitiligo has completed. Results from the study have been posted on 2025-11-17.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• AMG 714

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Vitiligo | Phase 2 | Status: COMPLETED | Results posted: 2025-11-17